Navigation Links
Common Cold Found to Fight Cancer Cells

Researchers have now found a way to genetically engineer the common cold virus so that it kills cancerous cells, while leaving healthy ones intact.// They did this by modifying one gene, so the virus could grow in cancerous cells. However, they had to boost the activity of another gene to ensure that the virus would not grow in non-cancerous cells. Specialists say, “When the virus infects cells, it takes the altered genes with it, and those genes attack cancer cells while leaving normal cells intact.”

Researchers say, in preclinical tests, the virus effectively attacked cancerous tumors and did not harm normal tissue. However researchers have been studying the common cold virus for the last 30 years and research is still on to test the virus in clinical trials.The potential is huge as some of the vectors are designed to destroy many different types of cancers and others are designed to be specific to colon or lung cancer.

The adenovirus is the virus responsible for the common cold. The latest technology is now patented, and researchers are collaborating to develop new therapies for cancer and other diseases that will be tested in a clinical setting.
'"/>




Page: 1

Related medicine news :

1. Common contraception
2. Common Cold Remedy May Treat SARS
3. Common Plant Triggers Asthma
4. Pain Common in People with MS
5. Common Cold Found to Fight Cancer
6. Bullying – a Common Problem Among Childre
7. Common Medication Errors in Children
8. A Common Cause Of Allergy That Goes Unnoticed
9. Genetic Breakthrough in Common Eye Problem
10. Side Effects Of Some Common Drugs
11. Analyzing The Side Effects Of Some Common Medications
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... In the ... to 300,000 people each year develop other types of metastatic brain tumors(3). Though most ... the brain(3). As efforts focus on finding more effective treatment options, the San ...
(Date:3/29/2017)... Massachusetts (PRWEB) , ... March 30, 2017 , ... Youth ... had great success and feedback from high school and college students who have participated ... being held July 7-23 and YFI is now accepting applications for enrollment. Visit ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... with or without a referral to new patients from Burnaby, BC. Patients in ... other full mouth reconstruction services, can see the esteemed team at Wall Centre ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... and other outpatient facilities, and who are the most active developers? , ... Revista and Healthcare Real Estate Insights (HREI) found that outpatient medical real estate ...
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly of synthetic DNA ... many repetitive steps and often scientists require many different versions of DNA. Therefore, ... results in a lower error rate and cost saving for reagents and consumables. ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017 Research and Markets has announced ... & Forecast By Type (Insource IONM, Outsource IONM), By Region ... their offering. ... The global Intraoperative Neuromonitoring (IONM) market is expected ... market is anticipated to witness significant growth in the forecast ...
(Date:3/29/2017)... Research and Markets has announced the addition ... their offering. ... The global gas chromatograph market to grow at a CAGR of ... Gas Chromatograph Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
(Date:3/29/2017)... HANOVER, N.J. , March 29, 2017 /PRNewswire/ ... Drug Administration (FDA) has accepted the company,s Biologics ... for CTL019 (tisagenlecleucel-T), an investigational chimeric antigen receptor ... (r/r) pediatric and young adult patients with B-cell ... BLA submission by Novartis for a CAR-T. The ...
Breaking Medicine Technology: